In NSCLC cells it was shown to inhibit TGF-β1-induced migration as well as EMT via the AKT/ERK signaling pathways [89], suggesting a modulatory effect on CSC properties. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.